Experience Summary and Medication Analysis of Master of Traditional Chinese Medicine ZHANG Jingsheng's CHD Therapy with Danshen Shengmai Yin (丹参生脉饮)

HOU Siyi; LENG Jinhong; YANG Guanlin; ZHANG Jingsheng

doi:10.13193/j.issn.1673-7717.2022.08.039

Suggestions

您当前的位置：

首页 >

文章列表页 >

Experience Summary and Medication Analysis of Master of Traditional Chinese Medicine ZHANG Jingsheng's CHD Therapy with Danshen Shengmai Yin (丹参生脉饮)

Previous: 无

Next: Discussion on the Mechanism and Clinical Application of "Heart Kidney Intersection" based on "Multi Visceral Coordination"

Experience Summary and Medication Analysis of Master of Traditional Chinese Medicine ZHANG Jingsheng's CHD Therapy with Danshen Shengmai Yin (丹参生脉饮)
1.The First Clinical Medical College of Liaoning University of Traditional Chinese Medicine, Shenyang 110847, Liaoning, China
2.Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang 110033, Liaoning, China
3.Liaoning University of Traditional Chinese Medicine, Shenyang 110847, Liaoning, China
DOI：10.13193/j.issn.1673-7717.2022.08.039

扫描看全文

HOU Siyi, LENG Jinhong, YANG Guanlin, et al. Experience Summary and Medication Analysis of Master of Traditional Chinese Medicine ZHANG Jingsheng's CHD Therapy with Danshen Shengmai Yin (丹参生脉饮)[DB/OL].（2022-11-18）[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails#10.13193/j.issn.1673-7717.2022.08.039
DOI：

HOU Siyi, LENG Jinhong, YANG Guanlin, et al. Experience Summary and Medication Analysis of Master of Traditional Chinese Medicine ZHANG Jingsheng's CHD Therapy with Danshen Shengmai Yin (丹参生脉饮)[DB/OL].（2022-11-18）[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails#10.13193/j.issn.1673-7717.2022.08.039 DOI：

摘要

国医大师张静生教授擅长治疗冠心病，有50余年临床经验。上世纪末，研制了以冠心康为基础方，以益气祛痰化瘀的方法治疗冠心病，收效甚好，然而，近20年人们嗜食辛辣食物、作息不规律、生活压力增加，生活行为发生了很大的改变，如今张教授认为冠心病以气阴两虚兼血瘀证为主，治法为益气养阴，活血化瘀，以丹参生脉饮为基础方：丹参、太子参、麦门冬、五味子4味。临床诊治时，常根据具体症状，组方时加用小方或经验对药，临床效果甚佳，甚或可使多支病变及高度狭窄患者症状缓解明显。

Abstract

Master of traditional Chinese medicine ZHANG Jingsheng, who has been engaged in traditional Chinese medicine for 50 years, is good at treating coronary heart disease (CHD) . At the end of the 20th century, Prof. ZHANG developed a new medicine named Guanxinkang (冠心康), which worked well in treating CHD by replenishing spleen Qi and dispelling phlegm and blood stasis. However, in the last 20 years, people faced craving for spicy food, irregular bedtime, and mounting social pressure. In such a situation, Prof. ZHANG thought that CHD was mainly caused by Qi-Yin deficiency and blood stasis, and its treating method should be replenishing Qi and nourishing Yin, invigorating blood circulation and removing blood stasis. The prescription is based on Danshen Shengmai Yin (丹参生脉饮), which includes four kinds of Chinese herbal medicine called Danshen (Salviae Miltiorrhizae Radix Et Rhizoma), Taizishen (Pseudostellariae Radix), Maimendong (Ophiopogonis Radix) and Wuweizi (Schisan-drae Chinensis Fructus) . In clinical diagnosis and treatment, Prof. ZHANG will add small prescriptions or drug pairs, according to individual symptoms and therapy experience. By this way, remarkable clinical effect can be achieved, which evenmakes obvi-ous relief to the multi-vessel pathological highly narrow patients.

关键词

丹参生脉饮冠心病张静生经验对药

Keywords

Danshen Shengmai Yin (丹参生脉饮)coronary heart diseaseZHANG Jingshengtherapy experiencedrug pairs

references

范维琥, 王文健. 慢性稳定型心绞痛的中西医结合治疗[J]. 上海医药, 2012, 33(2): 3-6.

邱丽芬, 马月香. 近十年中医治疗冠心病心绞痛研究进展[J]. 山东中医杂志, 2015, 34(4): 311-313.

刘萍, 张静生, 郑菲, 等. 中药对低密度脂蛋白受体基因表达的影响[J]. 中国中西医结合急救杂志, 2000, 7(3): 141-143.

刘萍, 张静生. 冠心康对高脂血症大鼠肝低密度脂蛋白受体基因表达的影响[J]. 中医杂志, 2003, 44(10): 777-779.

刘萍, 张静生. 冠心康对高脂血症大鼠肝脏低密度脂蛋白受体活性的影响[J]. 中国动脉硬化杂志, 2003, 11(2): 159-160.

刘会武, 张静生, 伊桐凝, 等. 冠心康对高脂血症兔血管LOX-1表达的影响[J]. 中国分子心脏病学杂志, 2007, 7(3): 135-137.

李开平, 张静生, 宫丽鸿. 冠心康对高同型半胱氨酸血症兔主动脉Bcl-2蛋白表达的影响[J]. 中华老年心脑血管病杂志, 2007, 9(5): 342-344.

伊桐凝, 张静生, 于世家. 冠心康颗粒对高同型半胱氨酸血症致兔动脉粥样硬化作用及对血管炎性因子表达影响[J]. 辽宁中医药大学学报, 2013, 15(11): 38-42.

张静生, 刘萍. 一种治疗冠心病的中药：辽宁，CN1583007[P]. 2005-02-23.

刘春芳, 侯丕华. 梁贻俊教授治疗冠心病心绞痛的经验[J]. 辽宁中医杂志, 1999, 26(6): 241.

郑金荣, 王兵. 生脉散加味治疗冠心病心绞痛的疗效观察[J]. 中国基层医药, 2003, 10(7): 684.

赵秀琴. 冠心病心绞痛56例观察[J]. 中医药学刊, 1994, 12(4): 35.

陆桂贵, 龙再超, 刘梅. 逐瘀生脉汤治疗胸痹[J]. 江西中医药, 1998, 29(5): 22.

吕宝经, 荣烨之, 朱向阳, 等. 生脉散颗粒剂对冠心病抗自由基和心肌缺血的作用[J]. 上海第二医科大学学报, 1999, 19(4): 319.

寇俊萍, 裴兴辰, 余伯阳, 等. 生脉散总皂苷对实验性心肌缺氧保护作用的研究[J]. 中医药学刊, 2004, 22(5): 822-824.

张子彬. 心力衰竭[M]. 济南: 山东科学技术出版社, 1986: 145.

卢成志, 张欣, 李玉光. 生脉注射液对大鼠心肌缺血再灌注时心肌细胞凋亡的影响[J]. 中华实用中西医杂志, 2004, 4(17): 553.

李翔, 张坚松, 李凤美. 生脉注射液对兔心肌缺血再灌注损伤MDA、SOD、ET、NO、CPK的影响[J]. 湖南医学高等专科学校学报, 2002, 4(4): 1-3.

周明学, 徐浩, 陈可冀, 等. 活血解毒中药有效部位对ApoE基因敲除小鼠动脉粥样硬化斑块炎症反应的影响[J]. 中西医结合心脑血管病杂志, 2007, 5(12): 1202-1205.

GAO S, LIU Z D, LI H, et al. Cardiovascular actions and therapeutic potential of tanshinone IIA[J]. Atheroscle-rosis, 2012, 220(1): 3-10.

李思铭, 李金根, 徐浩. 从抑制炎症反应看中医药干预冠心病的新视角[J]. 中国中西医结合杂志, 2019, 39(4): 486-490.

刘静, 牛一民, 李晓敏, 等. 丹参酮ⅡA对冠心病大鼠的影响[J]. 中国临床药理学杂志, 2020, 36(22): 3717-3720.

曾妮, 许妹萍, 庄丽明. 丹参素对大鼠动脉粥样硬化的作用及其机制[J]. 免疫学杂志, 2020, 36(10): 884-889, 896.

孙海英, 刘树文. 谷维素和黄连素合用治疗室性心律失常91例[J]. 陕西医学杂志, 2007, 36(7): 925-926.

李辉. 黄连素在心血管疾病中的应用[J]. 临床军医杂志, 2005, 33(4): 518-519.

邵江娟, 李蒙蒙, 付金柏. 牡蛎配伍葛根对自发性高血压(SHR)大鼠降血压作用机制研究[J]. 江苏中医药, 2017, 49(8): 75-78.

张金华, 邱俊娜, 王路, 等. 夏枯草化学成分及药理作用研究进展[J]. 中草药, 2018, 49(14): 3432-3440.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Application of Strengthening Yang and Activating Blood Method in Treatment of Coronary Heart Disease Based on "Yang Transforming into Qi, Yin Transforming into Shape"

The treatment of coronary heart disease and depression from five zang-organs

Application of "Wind Medicine" in the Treatment of Chest Pain after Revascularization

Experience in the Treatment of Coronary Heart Disease with Gualou, Xiebai, Danshen——Three Prescription by Professor TONG Xiaolin

Professor LI Yan's Experience in Treating CHD of Phlegm Stagnation and Blood Stasis

Related Author

No data

Related Institution

Graduate School of Beijing University of Chinese Medicine

Guang'anmen Hospital, China Academy of Chinese Medical Sciences

China Association of Chinese Medicine

Institute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Sciences

天津中医药大学第二附属医院

⁰